These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12639176)

  • 1. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
    Huggins RM; Scates AC; Latour JK
    Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous pantoprazole: a new tool for acutely ill patients who require acid suppression.
    Trépanier EF
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():11D-20D. PubMed ID: 11110607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine.
    Ley LM; Becker A; Lühmann R; Sander P; Lücker PW
    Methods Find Exp Clin Pharmacol; 2005; 27(1):25-9. PubMed ID: 15834456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
    Metz DC
    Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
    Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
    Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
    Martin RA
    Conn Med; 2004 Aug; 68(7):435-8. PubMed ID: 15384242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton-pump inhibitors for upper-gastrointestinal bleeding.
    Cohen H; Rebuck JA
    Am J Health Syst Pharm; 2006 Feb; 63(3):214, 216. PubMed ID: 16434778
    [No Abstract]   [Full Text] [Related]  

  • 11. Proton-pump inhibitors for upper-gastrointestinal bleeding.
    Rivkin K; Lyakhovetskiy A
    Am J Health Syst Pharm; 2006 Feb; 63(3):216-7. PubMed ID: 16434779
    [No Abstract]   [Full Text] [Related]  

  • 12. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study.
    Schepp W; Classen M
    Scand J Gastroenterol; 1995 Jun; 30(6):511-4. PubMed ID: 7569755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing role of H2-receptor antagonists in acid-related diseases.
    Lamers CB
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S3-7. PubMed ID: 8930573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding.
    Brunner G; Luna P; Hartmann M; Wurst W
    Yale J Biol Med; 1996; 69(3):225-31. PubMed ID: 9165691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
    Jensen DM; Pace SC; Soffer E; Comer GM;
    Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.
    Bersenas AM; Mathews KA; Allen DG; Conlon PD
    Am J Vet Res; 2005 Mar; 66(3):425-31. PubMed ID: 15822586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M
    Rev Prat; 2001 Apr; 51(7):789-95. PubMed ID: 11387678
    [No Abstract]   [Full Text] [Related]  

  • 19. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
    Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
    Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.